54, Rue La Boétie,
Paris,
75008
France,
+33 1 53 77 40 00
www.sanofi.com
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales.
| Year | ≤ '13 | '14 | '15 | '16 | '17 | '18 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | 18 | - | - | - | - | 1 | 19 |
| vol | $29.1B | $11.6B | $40.7B | |||||
| Sell (1.4/yr) | # | 2 | - | - | 2 | 2 | 3 | 9 |
| vol | $425M | $94M | $2.2B | $2.7B | ||||
| 28 | ||||||||
| Financial | Deals |
|---|---|
|
Sign-up to View
|
1 |
|
Sign-up to View
|
1 |
|
Sign-up to View
|
1 |
| Legal | Deals |
|---|---|
|
Sign-up to View
|
2 |
|
Sign-up to View
|
1 |
| Buy | # | TOTAL |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Genzyme Corp. $20.1B (2011-02-16) |
|
| Sell | # | Total |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| Total | Sign-up to View | |
| Largest |
Zentiva Group, a.s. $2.2B (2018-04-17) |
|
According to our data here at Mergr, Sanofi SA has acquired 21 companies, including 1 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 9 assets.
Sanofi SA’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2018, when it sold Zentiva Group a.s. to Advent International for $2.2B. Sanofi SA has acquired in 8 different US states, and 8 countries. The Company’s most targeted sectors include life science (53%) and medical products (22%).
When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 411 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.
Join Mergr and gain access to Sanofi SA’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
No obligation. Cancel anytime.
